Overall, our data provide motivation to better understand the tumor promotion and immune inhibition role of ALDH1A1/B1 in thyroid cancer patients, suggesting that ALDH1A1/B1 might serve as potential prognostic biomarkers for thyroid cancer treatment. Here, ALDH1A1 is linked to neoplasm.